{
    "clinical_study": {
        "@rank": "109328", 
        "brief_summary": {
            "textblock": "Glaucoma is a progressive disease resulting in loss of retinal nerve cells and their axons\n      (retinal nerve fibers). Retinal nerve fibers are ordered in a special manner when they enter\n      the optic nerve. Hence, damage to the retinal nerve fibers by glaucoma results in visual\n      field defects at certain locations. Furthermore, the retinal nerve fiber layers from\n      different receptors for different colors are ordered in a special manner as well. Thus, it\n      is possible that glaucomatous damage causes color vision dysfunction (dyschromatopsia).\n\n      At the moment there is disagreement whether dyschromatopsia occurs at early- to mid-stage or\n      only in end-stage glaucoma.\n\n      By testing color vision in glaucoma patients the prevalence of dyschromatopsia in glaucoma\n      and in different stages of the disease will be investigated."
        }, 
        "brief_title": "Prevalence of Dyschromatopsia in Glaucoma Patients", 
        "completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Open Angle Glaucoma", 
        "condition_browse": {
            "mesh_term": [
                "Glaucoma", 
                "Glaucoma, Open-Angle"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  diagnosis of open angle glaucoma\n\n          -  visual acuity >/= 20/50\n\n          -  age >/= 18 (no upper limit)\n\n          -  male or female gender\n\n        Exclusion Criteria:\n\n          -  other type of glaucoma\n\n          -  age <18\n\n          -  other retinal disease (e.g. age related macular degeneration)\n\n          -  other disease affecting the optic nerve or the retinal nerve fibers\n\n          -  known color blindness"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients with a diagnosis of open-angle glaucoma of the Glaucoma Department at\n        Massachusetts Eye & Ear Infirmary, Boston, MA 02114, US"
            }
        }, 
        "enrollment": {
            "#text": "0", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01994564", 
            "org_study_id": "356715-1 Dyschromatopsia"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "OAG", 
        "lastchanged_date": "November 19, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Boston", 
                    "country": "United States", 
                    "state": "Massachusetts", 
                    "zip": "02114"
                }, 
                "name": "Massachusetts Eye & Ear Infirmary"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Prevalence of Dyschromatopsia in Glaucoma Patients", 
        "overall_official": {
            "affiliation": "Massachusetts Eye & Ear Infirmary, Harvard Medical School, Boston, MA, US", 
            "last_name": "Douglas J. Rhee, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Withdrawn", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Color vision will be tested once by Ishihara plates. Both eyes will be tested separately.", 
            "measure": "Result from Ishihara Test", 
            "safety_issue": "No", 
            "time_frame": "Visit 1"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01994564"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Visual field will be tested with 30-2 Humphrey visual field full threshold test. Visual field defects will we graded following the Hodapp\u2010Anderson\u2010Parrish Scale (Hodapp E, Parrish RK, Anderson DR. Classification of Defects in Clinical Decisions in Glaucoma. St. Louis: Mosby, 1993:52-61).", 
            "measure": "Glaucoma stage", 
            "safety_issue": "No", 
            "time_frame": "Visit 1"
        }, 
        "source": "Massachusetts Eye and Ear Infirmary", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Massachusetts Eye and Ear Infirmary", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "July 2012"
    }
}